Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Ferroptosis

Items 1-10 of 14

Page
per page
  1. Piperazine Erastin
    C9128 Piperazine Erastin
    Summary: A ferroptosis inducer for research use that inhibits system xc? and promotes lipid peroxidation.
      ≥50.2 mg/mL
  2. Gallic acid
    N1830 Gallic acid
    Target: Antioxidants
    Summary: A natural polyphenolic compound with antioxidant, anti-inflammatory, antibacterial, and antitumor activities.
      insoluble in H2O; ≥5.95 mg/mL
  3. HAPSBC
    C8563 HAPSBC
  4. Imidazole ketone erastin
    C8432 Imidazole ketone erastin
    Summary: A potent, metabolically stable systemic xc- inhibitor and iron apoptosis inducer
      ≥107.1 mg/mL
  5. MMRi62
    BA2833 MMRi62
    Summary: MMRi62 is an iron death inducer that targets (oncogene p53 negative regulator).
      ≥50.4 mg/mL
  6. FIN56
    B8472 FIN56
    Summary: An inducer that triggers ferroptosis by inducing GPX4 degradation activity
      ≥52 mg/mL
  7. ML385
    B8300 ML385
     22 Citation
    Summary: NRF2 inhibitor
      insoluble in EtOH; insoluble in H2O; ≥13.33 mg/mL
  8. Dexrazoxane
    B3407 Dexrazoxane
    Summary: cardioprotective agent
      insoluble in H2O; insoluble in EtOH; ≥12 mg/mL
  9. Ammonium iron(III) citrate
    A4782 Ammonium iron(III) citrate
    Summary: A compound that induces ferroptosis and promotes protein production
      Soluble in DMSO
  10. DL-Buthionine-(S,R)-sulfoximine
    A4707 DL-Buthionine-(S,R)-sulfoximine
    Summary: A biosynthetic inhibitor for inhibiting γ-glutamylcysteine synthetase
      insoluble in DMSO; insoluble in EtOH; ≥30.4 mg/mL

Items 1-10 of 14

Page
per page